Location History:
- New Ziona, IL (1998)
- Nes Ziona, IL (1998 - 1999)
Company Filing History:
Years Active: 1998-1999
Title: Tamar Richter: Innovator in Biotechnology
Introduction
Tamar Richter is a prominent inventor based in Nes Ziona, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have therapeutic applications. With a total of 4 patents to her name, her work focuses on innovative methods to treat various cardiovascular and cerebrovascular disorders.
Latest Patents
Richter's latest patents include groundbreaking inventions related to the methods of using human von Willebrand factor GPIb binding domain. The subject invention provides non-glycosylated, biologically active polypeptides that comprise the vWF (von Willebrand Factor) GP1b binding domain. These polypeptides are designed to inhibit platelet adhesion and aggregation, which is crucial in treating conditions such as cerebrovascular and cardiovascular disorders. Additionally, her inventions encompass expression plasmids encoding these polypeptides, as well as methods for producing them by transforming bacterial cells and recovering the polypeptides. Furthermore, the subject invention outlines methods for treating and preventing cerebrovascular, cardiovascular, and other disorders using these polypeptides to inhibit platelet aggregation.
Career Highlights
Tamar Richter has established herself as a key figure in the biotechnology sector. She is currently associated with Bio-Technology General Corporation, where she continues to innovate and develop new therapeutic solutions. Her work has garnered attention for its potential impact on medical treatments and patient care.
Collaborations
Richter collaborates with Leonard Garfinkel, contributing to the advancement of their shared research goals. Their partnership exemplifies the collaborative spirit that drives innovation in the biotechnology field.
Conclusion
Tamar Richter's contributions to biotechnology through her innovative patents and collaborative efforts highlight her role as a leading inventor in the industry. Her work promises to enhance treatment options for patients with serious health conditions.